Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Ticagrelor Increases Exposure to the Breast Cancer Resistance Protein Substrate Rosuvastatin.
Clin Pharmacol Ther. 2024 Jan;115(1):71-79. doi: 10.1002/cpt.3067. Epub 2023 Oct 20.
Clin Pharmacol Ther. 2024.
PMID: 37786998
Clinical Trial.
Rhabdomyolysis during concomitant ticagrelor and rosuvastatin: A breast cancer resistance protein-mediated drug interaction?
Lehtisalo M, Kiander W, Filppula AM, Deng F, Kidron H, Korhonen M, Sinkko J, Koivula K, Niemi M.
Lehtisalo M, et al.
Br J Clin Pharmacol. 2023 Jul;89(7):2309-2315. doi: 10.1111/bcp.15684. Epub 2023 Feb 20.
Br J Clin Pharmacol. 2023.
PMID: 36740817
Review.
Item in Clipboard
A comprehensive pharmacogenomic study indicates roles for SLCO1B1, ABCG2 and SLCO2B1 in rosuvastatin pharmacokinetics.
Lehtisalo M, Taskinen S, Tarkiainen EK, Neuvonen M, Viinamäki J, Paile-Hyvärinen M, Lilius TO, Tapaninen T, Backman JT, Tornio A, Niemi M.
Lehtisalo M, et al.
Br J Clin Pharmacol. 2023 Jan;89(1):242-252. doi: 10.1111/bcp.15485. Epub 2022 Aug 22.
Br J Clin Pharmacol. 2023.
PMID: 35942816
Free PMC article.
Item in Clipboard
Febuxostat, But Not Allopurinol, Markedly Raises the Plasma Concentrations of the Breast Cancer Resistance Protein Substrate Rosuvastatin.
Lehtisalo M, Keskitalo JE, Tornio A, Lapatto-Reiniluoto O, Deng F, Jaatinen T, Viinamäki J, Neuvonen M, Backman JT, Niemi M.
Lehtisalo M, et al.
Clin Transl Sci. 2020 Nov;13(6):1236-1243. doi: 10.1111/cts.12809. Epub 2020 May 26.
Clin Transl Sci. 2020.
PMID: 32453913
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite